NM 136
Alternative Names: LOB-0136; NM-136Latest Information Update: 21 Sep 2023
Price :
$50 *
At a glance
- Originator Lobesity
- Developer 9 Meters Biopharma
- Class Monoclonal antibodies; Obesity therapies
- Mechanism of Action Gastric inhibitory polypeptide receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Obesity; Prader-Willi syndrome